Thanks! You've successfully subscribed to the BONEZONE®/OMTEC® Monthly eNewsletter!

Please take a moment to tell us more about yourself and help us keep unwanted emails out of your inbox.

Choose one or more mailing lists:
BONEZONE/OMTEC Monthly eNewsletter
OMTEC Conference Updates
Advertising/Sponsorship Opportunities
Exhibiting Opportunities
* Indicates a required field.

Arcam to Evaluate Strategic Alternatives for DTI

Arcam announced it will initiate a process to “explore and evaluate strategic alternatives regarding DiSanto Technology Inc. (DTI), to strengthen its focus and capabilities within both additive and conventional manufacturing.”

During this process, Arcam intends to consider a restructuring of DTI, a full or partial separation via a spin-off, sale, joint venture, strategic collaboration or other transaction. According to Arcam, its objective is to strengthen DTI’s ability to serve as a contract manufacturing partner to orthopaedic customers seeking to combine the benefits of additive manufacturing with traditional manufacturing capabilities.

Arcam purchased DTI in 2014 for US $15.8MM in cash and stock.

In 2016, Arcam was part of GE Additive’s U.S. $1.4BB investment in additive technology, materials and services worldwide.

Source: Arcam